Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
M&T Bank
MTB
$36.2B
| $32.3M | 0.04% |
208,720
+37,027
| +22% | +$5.99M |
|
377
PUT
Medtronic
MDT
$111B
| $32.3M | 0.04% |
400,900
+172,130
| +75% | +$13.4M |
|
378
Gen Digital
GEN
$16.9B
| $32M | 0.03% |
1,044,009
-160,033
| -13% | -$4.54M |
|
379
CALL
Procter & Gamble
PG
$345B
| $32M | 0.03% |
356,400
+5,800
| +2% | +$514K |
|
380
Northrop Grumman
NOC
$77.9B
| $32M | 0.03% |
134,570
+12,017
| +10% | +$2.85M |
|
381
PUT
Palo Alto Networks
PANW
$299B
| $32M | 0.03% |
1,701,600
-58,800
| -3% | -$1.31M |
|
382
CALL
Union Pacific
UNP
$173B
| $31.9M | 0.03% |
301,200
+164,900
| +121% | +$17.6M |
|
383
PUT
Bristol-Myers Squibb
BMY
$134B
| $31.7M | 0.03% |
582,600
-41,300
| -7% | -$2.27M |
|
|
RTN
384
DELISTED
Raytheon Company
RTN
| $31.6M | 0.03% |
207,175
-38,876
| -16% | -$5.85M |
|
|
CELG
385
PUT
DELISTED
Celgene Corp
CELG
| $31.5M | 0.03% |
253,500
-12,700
| -5% | -$1.52M |
|
|
ALXN
386
DELISTED
Alexion Pharmaceuticals
ALXN
| $31.4M | 0.03% |
259,316
+95,536
| +58% | +$12.3M |
|
387
MPLX
MPLX
$59.8B
| $31.4M | 0.03% |
871,263
-212,368
| -20% | -$7.82M |
|
388
PUT
Rio Tinto
RIO
$156B
| $31.3M | 0.03% |
768,400
-399,300
| -34% | -$17M |
|
|
RODI
389
DELISTED
iPath Return on Disability ETN
RODI
| $31.1M | 0.03% |
500,000
| – | – |
|
|
INFO
390
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $31.1M | 0.03% |
741,747
+26,189
| +4% | +$1.04M |
|
391
CALL
SLB Ltd
SLB
$73.2B
| $30.9M | 0.03% |
396,026
-17,300
| -4% | -$1.41M |
|
392
PUT
Morgan Stanley
MS
$332B
| $30.9M | 0.03% |
721,500
-1,636,200
| -69% | -$72.6M |
|
|
CERN
393
DELISTED
Cerner Corp
CERN
| $30.7M | 0.03% |
522,407
+135,840
| +35% | +$7.34M |
|
394
Workday
WDAY
$40.8B
| $30.7M | 0.03% |
369,090
-27,411
| -7% | -$2.28M |
|
395
CALL
Starbucks
SBUX
$120B
| $30.7M | 0.03% |
525,400
+58,200
| +12% | +$3.29M |
|
396
CALL
Autodesk
ADSK
$49.6B
| $30.7M | 0.03% |
354,700
+34,200
| +11% | +$2.86M |
|
|
WPZ
397
DELISTED
Williams Partners L.P.
WPZ
| $30.6M | 0.03% |
749,812
-44,798
| -6% | -$1.8M |
|
398
Travelers Companies
TRV
$78B
| $30.5M | 0.03% |
253,200
+42,928
| +20% | +$5.16M |
|
|
AGN
399
CALL
DELISTED
Allergan plc
AGN
| $30.4M | 0.03% |
127,300
-29,200
| -19% | -$6.8M |
|
400
Paychex
PAYX
$41.9B
| $30.3M | 0.03% |
513,850
+129,568
| +34% | +$7.87M |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.